Now showing items 1-10 of 17
A 13-Week, Randomized Double-Blind, Placebo-Controlled, Cross-Over Trial of Ziprasidone in Bipolar Spectrum Disorder
(LIPPINCOTT WILLIAMS & WILKINS, 2015)
Objective: Features of bipolarity in a major depressive disorder sample were used to define a "bipolar spectrum disorder" population for treatment with a neuroleptic agent, ziprasidone. Methods: Forty-nine acutely ...
Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone
(Associação Brasileira de Psiquiatria - ABP, 2011-03-01)
OBJECTIVE: To compare the effectiveness of intramuscular olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone as the first medication(s) used to treat patients with ...
Medicação de alto custo para portador de sofrimento psíquico: Um estudo preliminar dos custos
The present work aims to raise the costs of high-cost drugs used to treat patients of Refractory Schizophrenia in ambulatory unit. The study was carried out in the Psychosocial Support Center, which treated 33 patients ...
Drugs commonly associated with weight change: A systematic review and meta-analysis
(Oxford University Press, 2015)
Context: Various drugs affect body weight as a side effect. Objective: We conducted this systematic review and meta-analysis to summarize the evidence about commonly prescribed drugs and their association with weight change. ...
Efeitos dos neurolépticos atípicos ziprasidona e amisulprida em modelos animais de discinesia tardia
(Universidade Federal de São Paulo (UNIFESP), 2009-01-01)
Tardive dyskinesia - the main side effect of long-term treatment with typical neuroleptics - has been related to nigrostriatal dopaminergic supersensitivity. Treatment with atypical neuroleptics is associated with a decreased ...